Both ACE inhibitors and AGTR1 blockers (ARBs) were shown to inhibit tumor growth in animal models of breast, ovarian, lung, gastric and renal cancers7, and silencing AGTR2 expression suppressed the development of NNK-induced lung cancer12. Here, AGTR1 is linked to neoplasm.